Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
4
×
life sciences
clinical trials
deals
parkinson's disease
software
startups
tech
vc
abbvie
acorda therapeutics
aiq solutions
ampyra
apokyn
apomorphine
baird capital
beringea
bial
biotech
boston blog main
boston top stories
brian stern
centers for medicare & medicaid services
cerner
chronic conditions
cms
dalfampridine
diabetes
digital health
drug development
duopa
e-prescribing
ehr
ehrs
electronic health records
emr
emrs
epic
epic systems
eric horler
What
gets
4
×
patients
4
×
disease
fda
medical
new
nod
parkinson’s
acorda
add
aims
app
approved
called
carbidopa
cash
changes
combination
control
cope
daily
development
device
diet
digital
disorders
doctors
drug
drugs
economic
episodes
exercise
experience
friday
health
help
influx
late
levodopa
life
Language
unset
Current search:
patients
×
" national blog main "
×
gets
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
5 years ago
WI Watchlist: Montage, LÜM, WEDC, Titan Spine, Polco, Swallow & More
@xconomy.com
5 years ago
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms